Home / Import refusals / SCS-2067066-9/11/2

SCS-2067066-9/11/2

GlaxoSmithKline LLC — FEI 1033964

Recent inspections

  • 1229588 (VAI Fri Apr 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1043270 (NAI Fri Jan 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 987392 (VAI Thu Apr 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 940149 (NAI Fri Aug 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 841675 (NAI Fri May 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • NUV-3881703-0/70002/1 (Tue Feb 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9318923-9/110002/1 (Thu Feb 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9449370-5/10003/1 (Fri Feb 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-1894214-1/10003/1 (Wed Feb 04 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-1894214-1/20003/1 (Wed Feb 04 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

Refusal Details

Date
October 5, 2020
Country
United States
Product Category
Drugs and Biologics
Product Code
61ECY99 ANTI-ASTHMATIC, N.E.C.
Charges
75